Inhibition of angiogenesis decreases alveolarization in the developing rat lung

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 3 23-3, 2000, Pages

  Jakkula, Malathi ^a   Le Cras, Timothy D ^a   Gebb, Sarah ^a   Hirth, K Peter ^c   Tuder, Rubin M ^b   Voelkel, Norbert F ^b   Abman, Steven H ^a,d  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c SUGEN INC   (United States)

^d CHILDREN S HOSPITAL   (United States)

Author keywords

Bronchopulmonary dysplasia; Congenital diaphragmatic hernia; Fumagillin; Lung growth; Lung hypoplasia; Pulmonary circulation; Pulmonary hypertension; Thalidomide; Vascular endothelial growth factor

Indexed keywords

FUMAGILLIN; THALIDOMIDE;

ANGIOGENESIS; ANIMAL MODEL; ARTERIOGRAPHY; ARTICLE; CONTROLLED STUDY; DIAPHRAGM HERNIA; ENDOTHELIUM CELL; FETUS LIVER; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; LUNG DYSPLASIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0033826997     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.3.l600     Document Type: Article

References (51)

1. Pulmonary circulation and cardiovascular sequelae of BPD
2. Vascular endothelial growth factor gene expression in human fetal lung in vitro
3. Role of NO in the angiogenic response in vitro to basic fibroblast growth factor
4. Vascular development: Cellular and molecular regulation
5. 2
6. Alveolar dimensions and number: Developmental and hormonal regulation
7. Structural aspects of prenatal and postnatal development and growth of the lung
8. The pulmonary vascular bed in children with Down syndrome
9. The radial alveolar count method of Emery and Mithal: A reappraisal 1 - Postnatal lung growth
10. The radial alveolar count method of Emery and Mithal: A reappraisal 2 - Intrauterine and early postnatal lung growth
11. Pulmonary hypoplasia in Down's syndrome
12. Thalidomide is an inhibitor of angiogenesis
13. Pre- and postnatal development of the pulmonary circulation
14. Early fetal development of lung vasculature
15. Intermittent positive pressure hyperventilation with high inflation pressure produces microvascular injury in rats
16. The number of alveoli in the terminal respiratory unit of man during intrauterine life and childhood
17. Clinical applications of research on angiogenesis
18. Su-5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
19. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
20. VEGF is required for growth and survival in neonatal mice
21. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2
22. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
23. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)
24. Human lung growth in late gestation and in the neonate
25. Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat
26. Neonatal dexamethasone treatment increases the risk for pulmonary hypertension in adult rats
27. Morphometric analysis of the lung in bronchopulmonary dysplasia
28. Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition
29. Formation of pulmonary alveoli and gas-exchange surface area: Quantitation and regulation
30. Short-term perinatal 10% oxygen alters postnatal development of lung alveoli
31. Reduced gas transfer at rest and during exercise in school age survivors of bronchopulmonary dysplasia
32. NO mediates mitogenic effect of VEGF on coronary venular endothelium
33. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma
34. Inhibition by NO and NO-producing vasodilators of DNA synthesis in vascular smooth muscle cells
35. Vascular endothelial growth factor (VEGF) and its receptors
36. Inhibition of tumor growth and microvascular angiogenesis by the potent angiogenesis inhibitor, TNP-470, in rats
37. NO production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
38. Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40-day-old rats
39. Mechanisms of angiogenesis
40. Cell-cell and cell-matrix interactions in development of the lung vasculature
41. Epithelial-mesenchymal interactions in lung development
42. Flk-1 as a target for tumor growth inhibition
43. Synthesis and biological evaluations of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular tyrosine kinases
44. Brief perinatal hypoxia increases the severity of pulmonary hypertension after reexposure to hypoxia in infant rats
45. Lung volume, pulmonary vasculature, and factors affecting survival in congenital diaphragmatic hernia
46. Effect of NO on fetal pulmonary artery smooth muscle growth
47. Bronchopulmonary dysplasia: A morphometric study with emphasis on the pulmonary vasculature
48. Vascular endothelial growth factor/vascular permeability factor augments NO release from quiescent rabbit and human vascular endothelium
49. The postnatal development and growth of the human lung I. Morphometry
50. Angiogenesis and tumor metastasis
51. NO synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis